Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for Q1 2026 (January to March). The certificate from Registrar and Transfer Agent Aarthi Consultants Private Limited confirms the company properly processed share dematerialization requests during the quarter. This involved mutilating and cancelling physical share certificates, substituting the depository as the registered owner, and ensuring dematerialized securities remained listed on BSE (Scrip Code: 511509). The filing dated April 7, 2026 is a routine regulatory requirement that must be submitted within 15 days of quarter end.
This is a standard compliance filing with no direct impact on shareholders or stock price. It simply confirms proper processing of dematerialization requests as mandated by SEBI regulations.